The Palico Private Equity Fund Marketplace
Riverside Asia Fund is a private equity general partner firm located in Singapore.
The Riverside Company has made an investment in IPAR Rehabilitation, a provider of occupational rehabilitation case management solutions.
Riverside has bought Drex-Chem Malaysia, a specialty chemical distributor based near Kuala Lumpur.
The Riverside Company has acquired Australian orthopaedic implant manufacturer Global Orthopaedic Technologies for an undisclosed sum.
Read more news concerning Riverside Asia Fund
A sampling of Riverside Asia Fund portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?